
ABOUT PRECISION FOR MEDICINE
Precision for Medicine is an industry-leading global precision medicine clinical research organization and a leader in complex clinical development. Our clients benefit from advanced technologies and new approaches that compress timelines, gain efficiencies, and increase the probability of approval. Under one global roof, Precision has integrated sophisticated biomarker capabilities and laboratory expertise, worldwide CRO services, data intelligence solutions, and more. With 6 specialty labs and 3,500+ professionals worldwide, we help clients accelerate life-changing treatments and propel medicine forward.
FEATURED PRODUCTS
-
Precision starts at collection. The integrity of trial data depends on accurate, compliant, and traceable sample handling, but standard kitting isn’t built for the demands of biomarker-driven research.
-
Explore an integrated approach to support biomarker-driven development programs that accelerates your development timelines, helping you achieve your research goals faster and more effectively.
-
Learn about expert services specializing in precision medicine and biomarker-driven contract and clinical research that can assist you through translational solutions.
-
While automated inventory management systems play a crucial role in tracking samples, kit availability, and supply levels human involvement is still important to the adaptability of a clinical trial.
CONTACT INFORMATION
Precision for Medicine
2 Bethesda Metro Ctr Ste 850
Bethesda, MD 20814-5398
UNITED STATES
Contact: Nandita Handoo
FEATURED ARTICLES
-
Explore how the application of protein assays extend from basic research to the development of cutting-edge therapies, which makes them indispensable in the quest to improve human health.
-
Discover the rise in FDA-approved pediatric therapies and the role of precision medicine in tailoring treatments to genetic profiles, as well as how biomarkers and assays can enhance pediatric care.
-
Companion diagnostics (CDx) are crucial for personalized medicine to enable precise patient selection for therapies. Explore biomarker development strategies and early-phase study considerations to enhance your treatment efficacy.
-
Delve into the early development journey of a therapeutic antibody and learn about the critical role of robust biomarker strategies and analytical assays.